维普中文期刊产品整合服务
7篇 您的检索式:作者名="Mosunjac M"
    题名 作者 年代 出处 被引量
1Fine-needle aspiration biopsy and intraop- crative cytologic smear findings in a case of benign mesothefial-cell inclusions involving a lymph node: case report and review of the literature 显示文摘Paul1 G Mosunjac M 2003Diagn Cytopathol2003,29,3:1
2Norepinephrine enhances adhesion of HIV-1-infected leukocytes to cardiac microvascular endothelial cells显示文摘SUNDSTROM J B MARTINSON D E MOSUNJAC M 2003Exp Biol Med2003,228,3:1
3Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases 显示文摘Sundstrom J B Mosunjac M Martinson DE 2001AIDS Res Hum Retroviruses2001,17,17:1
4Hepatoid adenocarcino- ma of the lung : a case report and review of the literature 显示文摘Shaib W Sharma R Mosunjac M 2014J Gastrointest Cancer2014,45,1:1
5Enhanced down- regulation of ALCAM/CD166 in African-American Breast Cancer显示文摘Tan F Mosunjac M Adams AL 2014BMCCancer2014,14,:1
6Development of fatal acute liver failure in HIV-HBV coinfected patients显示文摘Coinfection with hepatitis B virus(HBV) is not uncommon in human immunodeficiency virus(HIV)-infected individuals and patients with HIV-HBV coinfection are at high risk for progression of liver disease.Current guidelines regarding the treatment of HIV infection recommend that patients who are coinfected with HIV and HBV receive highly active antiretroviral therapy(HAART) with activity against hepatitis B.While HIVHBV coinfected patients often experience liver enzyme elevations after starting antiretroviral therapy,acute liver failure(ALF) is rare and typically occurs with older antiretroviral agents with known potential for hepatotoxicity.We describe two cases of fatal ALF in the setting of HIV-HBV coinfection after initiation of HAART.These cases occurred despite treatment with antiretrovirals that have activity against HBV and highlight the challenges in distinguishing drug hepatotoxicity and HBV immune reconstitution inflammatory syndrome.HIV-HBV coinfected patients should be monitored closely when initiating HAART,even when treatment includes agents that have activity against HBV.Albert M Anderson Marina B Mosunjac Melody P Palmore Melissa K Osborn Andrew J Muir 2010World Journal of Gastroenterology2010,16,32:1
7Hepatoid Adanocarcinoma of the Lung: A Case Report and Review of the Literature显示文摘Shaib W Sharma R Mosunjac M 2014J Gastrointest Cancer2014,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费